Show Stocks and Investing Publications • Fri, March 3, 2023
Anupam Rama Maintained (SRPT) at Buy with Increased Target to $206 on, Mar 3rd, 2023
ama-maintained-srpt-at-buy-with-increased-target-to-206-on-mar-3rd-2023.html
Stocks and Investing on Mon, Oct 28th, 2024Anupam Rama of JP Morgan, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $153 to $206 on, Mar 3rd, 2023.
Anupam has made no other calls on SRPT in the last 4 months.
There are 12 other peers that have a rating on SRPT. Out of the 12 peers that are also analyzing SRPT, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Judah Frommer of "Credit Suisse" Maintained at Hold with Increased Target to $144 on, Wednesday, March 1st, 2023
These are the ratings of the 11 analyists that currently disagree with Anupam
- Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $171 on, Wednesday, March 1st, 2023
- Gil Blum of "Needham" Maintained at Strong Buy with Increased Target to $200 on, Wednesday, March 1st, 2023
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $180 on, Wednesday, March 1st, 2023
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $187 on, Wednesday, March 1st, 2023
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, March 1st, 2023
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $226 on, Wednesday, March 1st, 2023
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $202 on, Wednesday, March 1st, 2023
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy and Held Target at $160 on, Tuesday, February 28th, 2023
- Joseph Schwartz of "SVB Leerink" Reiterated at Buy and Held Target at $160 on, Friday, January 20th, 2023
- Yun Zhong of "BTIG" Maintained at Strong Buy with Increased Target to $160 on, Thursday, December 22nd, 2022
- Colin Bristow of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $158 on, Friday, December 16th, 2022